NEA Partners 13, Limited Partnership, 10% Owner at Ra Pharmaceuticals, Inc. (RARX), bought 1,290,322 shares at $15.50 ($20.0M) on 2018-12-14, disclosed to the SEC on 2018-12-14.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $15.50 | 645,161 | $10.0M | 50.0% |
| 2 | $15.50 | 645,161 | $10.0M | 50.0% |
| Total | $15.50 avg | 1,290,322 | $20.0M | 100% |
| Filing → |
| TSRO | BUY | 2018-03-06 | $6.6M | — | Filing → |
| RYTM | BUY | 2017-10-10 | $9.3M | — | Filing → |
| ROKA | BUY | 2014-07-22 | $4.6M | — | Filing → |